本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

12.91
-0.0300-0.23%
盘后12.910.00000.00%19:30 EDT
成交量:125.76万
成交额:1,629.46万
市值:10.81亿
市盈率:-20.65
高:13.50
开:13.13
低:12.77
收:12.94
52周最高:26.95
52周最低:5.64
股本:8,376.77万
流通股本:7,412.01万
量比:1.31
换手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-0.6252
每股收益(LYR):-0.5320
净资产收益率:-35.43%
总资产收益率:-21.66%
市净率:4.80
市盈率(LYR):-24.27

数据加载中...

2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/17

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/11/01

重要事件披露

8-K - Current report
2021/11/01

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals